TGA Approval

ENTYVIO vedolizumab 300 mg powder for injection vial (210048)

ARTG ID

210048

ARTG Name

ENTYVIO vedolizumab 300 mg powder for injection vial

Sponsor

Takeda Pharmaceuticals Australia Pty Ltd

ARTG Date

June 27, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-CMI-03349-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-02140-1

Ingredient Name

vedolizumab

Empowering clinical research with data-driven insights and AI-powered tools.

ENTYVIO vedolizumab 300 mg powder for injection vial (210048) - TGA 批准文号 | MedPath